iwNHL 2026 Live Session Presentations

The 23rd International Workshop on Non-Hodgkin Lymphoma (iwNHL) took place in Boston, MA on September 18–20, 2026. Esteemed experts gathered to discuss the latest research findings in NHL and strategies to enhance patient outcomes. iwNHL 2026 was supported by Platinum Sponsors: AbbVie, AstraZeneca, Genentech, and Genmab; Gold Sponsors: BeOne Medicines and Bristol Myers Squibb; Silver Sponsors: Caribou Biosciences, Eli Lilly and Company, and Novartis; Bronze Sponsors: ADC Therapeutics, Lyell Immunopharma, Natera, Nurix Therapeutics, Regeneron Pharmaceuticals, and Secura Bio; and Supporter: Arvinas. Sponsors of the workshop have no influence over the production of content.

Highlight Reel Live Session Presentations Session Recaps Photo Gallery

S01 Controversies in T-Cell Lymphoma › S02 Controversies in Mantle Cell Lymphoma › S03 Keynote Address › S04 Translational Research in Aggressive Lymphomas › S05 Novel Therapies › S06 Expanding CAR T-Cell Therapy › S07 Patient Advocacy in Lymphoma › S08 Debate – CAR T-Cell Failure › S09 Bispecific and Trispecific Antibodies in NHL › S10 AI Is Coming › S11 CAR T-Cells Stuck in Second Gear › S12 MRD Testing in NHL › S13 How Can We Succeed ›

S01 Controversies in T-Cell Lymphoma

Session Agenda